<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <issn pub-type="ppub">1613-0073</issn>
    </journal-meta>
    <article-meta>
      <title-group>
        <article-title>Clinical Intervention Efectiveness Estimation through Dynamic Bayesian Network</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>Alessandro Bregoli</string-name>
          <email>a.bregoli1@campus.unimib.it</email>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Luca Neri</string-name>
          <email>luca.neri@fmc-ag.com</email>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Len Usvyat</string-name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Francesco Bellocchio</string-name>
          <email>francesco.bellocchio@fmc-ag.com</email>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Fresenius Medical Care Italia S.p.A.</string-name>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Palazzo Pignano</string-name>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Italy</string-name>
        </contrib>
        <aff id="aff0">
          <label>0</label>
          <institution>Department of Informatics</institution>
          ,
          <addr-line>Systems and Communication</addr-line>
          ,
          <institution>University of Milano-Bicocca</institution>
          ,
          <country country="IT">Italy</country>
        </aff>
        <aff id="aff1">
          <label>1</label>
          <institution>Fresenius Medical Care North America</institution>
          ,
          <addr-line>Waltham</addr-line>
          ,
          <country country="US">US</country>
        </aff>
      </contrib-group>
      <abstract>
        <p>Determining whether to proceed with a clinical intervention can be a challenging task due to the numerous variables at play. One of the most crucial piece of information for making this decision is a precise assessment of the intervention's efectiveness, but it tends to be a complex calculation for healthcare professionals. In hemodialysis patients, the presence of a functional arteriovenous fistula (AVF) is essential to achieve a suficient dialysis dosage and prevent various complications. Percutaneous transluminal angioplasty (PTA) is a commonly employed procedure to restore the patency of AVFs. However, it carries the disadvantage of causing long-term vessel damage, thereby reducing the lifespan of the AVF. In this preliminary study we explore Dynamic Bayesian Network (DBN) to estimate the efectiveness of the next PTA from the elaboration of routinely collected clinical data. We build a DBN to predict the risk of problems of AVF and simulate how the next PTA could impact this prediction. The outcomes of this research could contribute to the development of a decision support system for vascular surgeons, aiding in the optimization of the decision-making process regarding whether to proceed with a PTA and/or consider alternative solutions.</p>
      </abstract>
      <kwd-group>
        <kwd>Network</kwd>
        <kwd>Dynamic Bayesian Network</kwd>
        <kwd>hemodialysis</kwd>
        <kwd>arteriovenous fistula</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec-1">
      <title>-</title>
      <p>CEUR
ceur-ws.org</p>
    </sec>
    <sec id="sec-2">
      <title>1. Introduction</title>
      <p>
        Percutaneous transluminal angioplasty (PTA) stands out as a common surgical intervention
to treat stenosis or occlusion of a malfunctioning arteriovenous fistula (AVF) [
        <xref ref-type="bibr" rid="ref1">1</xref>
        ]. Occluded
or partially occluded AVF decreases the eficacy of hemodialysis treatment, increasing the
risk of several negative patient’s outcomes. As dialysis is a critical care for patient survival,
when the hemodialysis eficacy goes under a certain threshold, the patient needs a diferent
vascular access to perform such treatment. PTA involves the use of a balloon catheter to dilate
narrowed or blocked vessels, restoring blood flow and improving AVF functionality. The success
of PTA, and the lasting of this success, depends on several factors as: vascular surgeon abilities,
AVF’s anatomical and functional characteristics, patient characteristic and previous invasive
†These authors contributed equally.
CEUR
Workshop
Proceedings
interventions. PTA generally solves the acute problem, reestablishing the patency of AVF, but
can also create a further vessel damage shortening the future AVF free intervention period. The
decision to intervene with a PTA or to create a new AVF (and/or a diferent vascular access),
is a cost-benefits decision involving many variables. If the physician expects that a new PTA
would keep the AVF functioning for a very short time, he might consider a diferent option
as the creation of a new AVF, switching to another type of vascular access as Central Venous
Catheter, or a combination of the previous options. This decision is not trivial as a new AVF
required 3-4 months to be ready for the use and catheter is generally considered less preferable
for the higher risk of infection. On the other hand, PTA has some risk related to the surgical
intervention per se and creates discomfort for such fragile patients. Estimating the duration
of the AVF functioning period is critical to take the best decision for the patient, but it is very
dificult for a clinician, considering the fact that there is a high number of variables that play
a role in this process. In this preliminary study, we tried to build a model based on Dynamic
Bayesian Network to estimate the efectiveness of the next PTA considering routinely collected
clinical data.
      </p>
    </sec>
    <sec id="sec-3">
      <title>2. Method</title>
      <sec id="sec-3-1">
        <title>2.1. Dataset</title>
        <p>Our dataset was composed of 143,454 AVF assessments referred to 4,718 hemodialysis patients
from Portugal and collected between 2015 and 2022. The dataset was composed of 7 parameters
that characterize the AVF functioning and the history of AVF problems (number of PTAs and
failures in the past). We exploit two metrics (average and delta) of the Arterial and Venous
Pressure in the last 30 days as proxy of blood flux in the AVF. These two pressures are measured
by the dialysis treatment machine and represent the pressure of the blood in the line carrying
the blood from the patient to the machine (venous line) and the pressure in the line carrying
the blood from the machine to the patient (arterial line). The variables used in the model are
described in the following:
• AVF Failure: is a discrete variable that describe the status of the AVF. It can assume 3
values: - No Failure: the AVF worked fine during the month, PTA: a PTA was performed
during the month - Failure: a problem prevented the use of the AVF during the month
• Count PTA: number of PTAs previously performed.
• Mean Venous Pressure: Average venous pressure measured by the dialysis machine during
the month.
• Delta Mean Venous Pressure: Relative diference between the mean venous pressure
measured in the month with that measured in the previous month.
• Mean Arterial Pressure: mean arterial pressure measured by the dialysis machine during
the month.
• Delta Mean Arterial Pressure: Relative diference between the mean arterial pressure
measured in the month and that measured in the previous month.
• Stenosis: Presence of a stenosis during the month. This variable is only partially observed.</p>
        <p>In fact, we are certain of a stenosis only if specific tests are carried out or if PTA is
performed.</p>
        <p>
          All this information are routinely recorded through the Fresenius Medical Care health care
system called EuCliD® [
          <xref ref-type="bibr" rid="ref2">2</xref>
          ]. Written informed consent for statistical analysis was obtained from
all the patients.
        </p>
      </sec>
      <sec id="sec-3-2">
        <title>2.2. (Dynamic) Bayesian Networks</title>
        <p>
          Bayesian Networks (BNs) are probabilistic network models [
          <xref ref-type="bibr" rid="ref3">3</xref>
          ] capable of representing
probabilistic knowledge. The BN framework can be divided into two components: quantitative
and qualitative. The qualitative element is a Directed Acyclic Graph (DAG) encoding a set of
conditional dependences and independences among a set of random variables. The
quantitative element describes the relationships among random variables with probability theory [
          <xref ref-type="bibr" rid="ref4">4</xref>
          ].
Formally a BN is defined as follows: BN = ( ,  ,  ) . Where  is the set of random variables,
 = ( , ) is a DAG representing conditional independences among variables in  and 
is a set of conditional probability distributions. The construction of a BN requires to learn
both the qualitative component  and the quantitative component  . The learning phase can
be carried out using data, expert knowledge or a mixed strategy. The latter approach can be
efectively applied in healthcare where the domain expert knowledge can be integrated with
data [
          <xref ref-type="bibr" rid="ref5">5</xref>
          ]. Bayesian networks do not explicitly model time. For this reason, the Dynamic Bayesian
Networks (DBN) framework was developed [
          <xref ref-type="bibr" rid="ref6">6</xref>
          ]. A DBN describes the evolution of the system
by modeling its variables over diferent time slices. The most basic form of DBN satisfies the
ifrst order Markov property and it is called 2 time slice DBN (2TBN). The 2TBN can be formally
described as follows: 2TBN = ( ,  2TBN,  ) where:
•  is the set of variables variables evolving through time.
•  is a set of conditional probability distributions.
•  2TBN = ( 2TBN,  2TBN) is a DAG encoding a set of conditional dependences and
independences among a set of random variables. Here lies the main diference between BNs
and DBNs
–  2TBN =   0 ∪    is the set of nodes:
∗   0 represents the variables  at time 0.
        </p>
        <p>∗    represents the variables  at a generic time t.
–  2TBN ⊂  2TBN ×  2TBN is the set of edges:
∗   0 = (  0 ×   0) ∩  2TBN: is the set of edges enconding the relations among the
variable at time 0
∗    = (   ×    ) ∩  2TBN: is the set of edges enconding the relations among the
variable at time a generic time t
∗   ,+1 = (  0 ×    ) ∩  2TBN: is the set of edges enconding the relations among
the variables through time from a generic time  to  + 1 .</p>
        <p>The strength of DBNs is that they employ the same solving and learning algorithms used for
BNs. As for the inference phase, it is possible to use the inference algorithms used for BNs but
the DBN must be unrolled first.</p>
      </sec>
    </sec>
    <sec id="sec-4">
      <title>3. Results</title>
      <p>
        In this section, we aim to utilize a 2TBN to analyze the temporal dependencies of various factors
associated with AVF development and failure. By constructing a 2TBN model using expert
knowledge and patient data, we can explore the dynamic interactions between variables and
estimate the intervention free period for an AVF. Exploring the dataset we found 2,598 PTAs and
4,837 events classified as AVF failure (stopping AVF use or an important medical intervention on
AVF). As a result, the AVF intervention free period decreases with each PTA (Table 1). However,
these values vary greatly from patient to patient. These observations are in line with those
obtained by the authors of [
        <xref ref-type="bibr" rid="ref7">7</xref>
        ], who observed that the risk of failure is directly proportional to
the number of past failures1. The model we are going to present has the main goal of estimating
the intervention free survival for the specific patient.
      </p>
      <sec id="sec-4-1">
        <title>3.1. Structure of the 2TBN</title>
        <p>We decided to base the identification of the structure of the 2TBN on domain knowledge and
the result is depicted in Figure 1. We can split the structure in three main components:
TIME 0 The left side of Figure 1 represents the nodes   0, the edges   0 and models the
dependencies among the variables for the first time slice (month 0). In this component, the
pressures depends on the presence of stenosis. All the edges completely contained on the right
side of the figure (green edges) have no temporal connotation and do not describe any evolution.
TIME t The right side of Figure 1 represents the nodes    , the edges    and describe the
dependencies among the variables at a generic month &gt; 0. Similarly to the previous paragraph,
also in this case all the edges completely contained on the right side of the figure (red edges)
have no temporal connotation and do not describe any evolution.</p>
        <p>Time dependence All the edges crossing from the left side to the right side of Figure 1
(orange edges) are the edges   ,+1 and describe the dependencies of the variables at a generic
month given the variables of the previous month. These are the only edges that have a temporal
connotation and describe the evolution of the process over time.
1In this study, diferent types of failures are taken into account. However stenosis is on of the most frequent causes.</p>
        <p>TIME 0
AVF Failure</p>
        <p>Count PTA
Stenosis</p>
        <p>TIME t</p>
        <p>Stenosis
AVF Failure</p>
        <p>Count PTA</p>
        <p>Mean
Venous Pressure</p>
        <p>Observing the right component and the crossing edges we can see that all the pressures
mainly depend on the presence/absence of stenosis. Furthermore we can see how the failure of
the AVF or the need to do a PTA depend solely on the information from the previous month.</p>
      </sec>
      <sec id="sec-4-2">
        <title>3.2. Parameters of the 2TBN</title>
        <p>
          The parameters of the 2TBN are learned from the dataset. First of all, we discretized the
continuous variables (pressure). We experimented with various methods during the discretization
process, including uniform, quantile-based, and expert knowledge-based approaches. We
discovered that discretization based on expert knowledge was the most efective solution. Specifically,
we categorized the data into five pressure levels: very low pressure, low pressure, normal
pressure, high pressure, and very high pressure. Then, since we have a partially observed
variable (stenosis) we used the Expectation Maximization algorithm to learn the parameters [
          <xref ref-type="bibr" rid="ref4">4</xref>
          ].
The implementation used for learning is the one provided in the package pyAgrum [
          <xref ref-type="bibr" rid="ref8">8</xref>
          ]. Since
correctly modeling the evolution of a stenosis is the fundamental component of this model we
will focus on the parameters learned for this variable. Table 2 reports the parameters for the
variable stenosis at time   and shows that the probability of developing a stenosis increases
with the number of previous PTA. Furthermore, PTA loses efectiveness if performed more than
3 times on the same AVF.
        </p>
      </sec>
      <sec id="sec-4-3">
        <title>3.3. Inference</title>
        <p>and the edges   ,+1</p>
        <p>(Figure 2).</p>
        <p>
          Classical BN exact or approximate algorithms [
          <xref ref-type="bibr" rid="ref4">4</xref>
          ] can be used to perform inference over DBN.
However, before utilizing these algorithms, it is necessary to unroll the network. Unrolling
involves replicating the nodes and edges of the 2TBN for each time step. Each duplicate
represents the variables’ states at a specific time step, and contains all the nodes    , the edges
( 0)
        </p>
        <sec id="sec-4-3-1">
          <title>False</title>
        </sec>
        <sec id="sec-4-3-2">
          <title>True</title>
        </sec>
        <sec id="sec-4-3-3">
          <title>False</title>
        </sec>
        <sec id="sec-4-3-4">
          <title>True</title>
        </sec>
        <sec id="sec-4-3-5">
          <title>False</title>
        </sec>
        <sec id="sec-4-3-6">
          <title>True</title>
        </sec>
        <sec id="sec-4-3-7">
          <title>False</title>
        </sec>
        <sec id="sec-4-3-8">
          <title>True</title>
        </sec>
        <sec id="sec-4-3-9">
          <title>False</title>
        </sec>
        <sec id="sec-4-3-10">
          <title>True</title>
        </sec>
        <sec id="sec-4-3-11">
          <title>False</title>
        </sec>
        <sec id="sec-4-3-12">
          <title>True</title>
        </sec>
        <sec id="sec-4-3-13">
          <title>False</title>
        </sec>
        <sec id="sec-4-3-14">
          <title>True</title>
        </sec>
        <sec id="sec-4-3-15">
          <title>False</title>
        </sec>
        <sec id="sec-4-3-16">
          <title>True</title>
        </sec>
        <sec id="sec-4-3-17">
          <title>False</title>
        </sec>
        <sec id="sec-4-3-18">
          <title>True</title>
        </sec>
        <sec id="sec-4-3-19">
          <title>False</title>
        </sec>
        <sec id="sec-4-3-20">
          <title>True</title>
        </sec>
        <sec id="sec-4-3-21">
          <title>False</title>
        </sec>
        <sec id="sec-4-3-22">
          <title>True</title>
        </sec>
        <sec id="sec-4-3-23">
          <title>False</title>
        </sec>
        <sec id="sec-4-3-24">
          <title>True</title>
        </sec>
        <sec id="sec-4-3-25">
          <title>False</title>
        </sec>
        <sec id="sec-4-3-26">
          <title>True</title>
        </sec>
        <sec id="sec-4-3-27">
          <title>False</title>
        </sec>
        <sec id="sec-4-3-28">
          <title>True</title>
        </sec>
        <sec id="sec-4-3-29">
          <title>False</title>
          <p>True</p>
        </sec>
      </sec>
      <sec id="sec-4-4">
        <title>3.4. Application</title>
        <p>Our developed 2TBN can serve as a tool for predicting the AVF intervention free period post
PTA, assisting doctors in determining the need for a new AVF creation for the patient. In
particular, the described model can be utilized in the subsequent manner: when a vascular
surgeon determines that a patient needs to undergo a PTA, inputs the relevant data from the
current month into the model. Then, the physician hypothesizes performing a PTA in the
upcoming month and requests the model to predict the chances of failure or the requirement
for an additional PTA over the span of 6 months following the initial procedure. To evaluate
the performance of the learned model we randomly selected 70% of the patients as train and we
used the remaining 30% of the patients as test. Of the 2,598 PTAs reported in the dataset, 2,106
are in the train set and 492 are in the test set. Of the 492 PTAs present in the test set, 226 failed
within 6 months following the operation. We learned the model on the train set and then we
used the test set to see how well it predicts the AVF intervention free period using the AUC
score obtaining a value of 0.64.</p>
      </sec>
    </sec>
    <sec id="sec-5">
      <title>4. Discussion</title>
      <p>
        A well functioning AVF is essential for performing efective hemodialysis treatment and
maintaining the overall health of a patient dependent on dialysis. Nevertheless, this vascular access
can undergo biological alterations, potentially rendering it unsuitable for dialysis procedures.
One primary factor contributing to issues associated with AVF is the stenosis. This problem is
often treated with a surgical procedure called PTA, that generally restores the patency of the
AVF in the short term but can cause vessel damage and problems in the long term. Every time a
stenosis is detected, the physician must ask himself whether a PTA is suficient or whether it is
necessary to create a new AVF. To help the doctor in this dificult decision we developed a model
that predicts the risk of AVF problems when a PTA is performed. We selected DBN paradigm
to tackle this problems for two main reasons. First, we evaluated as important the use of an
approach able to exploit the information coming from data and experts knowledge. Second, in
this problem, the risk of having AVF failure is influenced by the PTA and the PTA influences
the future risk of AVF failure, so to represent this kind of loop we needed an approach able to
consider the relationship among variables along time. The standard BNs do not accomplish this
requirement while DBNs do. Specifically, we developed a 2TBN were each time slice covers a
month. The presented model is in an early stage and presents many limitations. First of all, the
ifnal accuracy of the prediction (AUC=0.64) that is insuficient for the clinical use. This limited
accuracy might be related to the fact that we are ignoring the location of the stenosis in the
AVF. Diferent locations can have diferent efects on the pressures. In the future we would
like to add this information so we can include it in the model. Another strong limitation is the
requirement to discretize the variables. Especially for pressures, this operation is extremely
delicate and can lead to a distortion in the data. One potential solution to address the issue
of discretization could involve the implementation of semi-parametric BNs [
        <xref ref-type="bibr" rid="ref9">9</xref>
        ], enabling the
direct inclusion of continuous variables within the model. In conclusion, we are aware of the
large limitations of such a simple model. However, we are convinced that this paper can be a
starting point for the development of a model capable of supporting physicians and patients in
the complex decision-making process related to AVF management.
      </p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <mixed-citation>
          [1]
          <string-name>
            <given-names>J. Fazendeiro</given-names>
            <surname>Matos</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Iglesias</surname>
          </string-name>
          ,
          <string-name>
            <given-names>C.</given-names>
            <surname>Miriunis</surname>
          </string-name>
          ,
          <string-name>
            <given-names>F.</given-names>
            <surname>Pelliccia</surname>
          </string-name>
          ,
          <string-name>
            <surname>I. Morris</surname>
          </string-name>
          , I. Romach,
          <string-name>
            <given-names>M.</given-names>
            <surname>Preda</surname>
          </string-name>
          ,
          <string-name>
            <given-names>N.</given-names>
            <surname>Ward</surname>
          </string-name>
          ,
          <string-name>
            <given-names>R.</given-names>
            <surname>Beltrandi</surname>
          </string-name>
          ,
          <string-name>
            <given-names>R.</given-names>
            <surname>Peralta</surname>
          </string-name>
          , T. Kafkia, Vascular Access, Cannulation and Care,
          <string-name>
            <surname>EDTNA</surname>
          </string-name>
          ,
          <year>2015</year>
          .
        </mixed-citation>
      </ref>
      <ref id="ref2">
        <mixed-citation>
          [2]
          <string-name>
            <given-names>H.</given-names>
            <surname>Steil</surname>
          </string-name>
          ,
          <string-name>
            <given-names>C.</given-names>
            <surname>Amato</surname>
          </string-name>
          ,
          <string-name>
            <given-names>C.</given-names>
            <surname>Carioni</surname>
          </string-name>
          ,
          <string-name>
            <given-names>J.</given-names>
            <surname>Kirchgessner</surname>
          </string-name>
          ,
          <string-name>
            <given-names>D.</given-names>
            <surname>Marcelli</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Mitteregger</surname>
          </string-name>
          ,
          <string-name>
            <given-names>V.</given-names>
            <surname>Moscardo</surname>
          </string-name>
          ,
          <string-name>
            <given-names>G.</given-names>
            <surname>Orlandini</surname>
          </string-name>
          , E. Gatti, Euclid®
          <article-title>-a medical registry</article-title>
          ,
          <source>Methods of information in medicine 43</source>
          (
          <year>2004</year>
          )
          <fpage>83</fpage>
          -
          <lpage>88</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref3">
        <mixed-citation>
          [3]
          <string-name>
            <given-names>J.</given-names>
            <surname>Pearl</surname>
          </string-name>
          ,
          <article-title>Probabilistic reasoning in intelligent systems: networks of plausible inference</article-title>
          , Morgan kaufmann,
          <year>1988</year>
          .
        </mixed-citation>
      </ref>
      <ref id="ref4">
        <mixed-citation>
          [4]
          <string-name>
            <given-names>U. B.</given-names>
            <surname>Kjaerulf</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A. L.</given-names>
            <surname>Madsen</surname>
          </string-name>
          ,
          <source>Bayesian networks and influence diagrams</source>
          ,
          <source>Springer Science+ Business Media</source>
          <volume>200</volume>
          (
          <year>2008</year>
          )
          <fpage>114</fpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref5">
        <mixed-citation>
          [5]
          <string-name>
            <given-names>E.</given-names>
            <surname>Kyrimi</surname>
          </string-name>
          ,
          <string-name>
            <given-names>S.</given-names>
            <surname>McLachlan</surname>
          </string-name>
          ,
          <string-name>
            <given-names>K.</given-names>
            <surname>Dube</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M. R.</given-names>
            <surname>Neves</surname>
          </string-name>
          ,
          <string-name>
            <given-names>A.</given-names>
            <surname>Fahmi</surname>
          </string-name>
          ,
          <string-name>
            <given-names>N.</given-names>
            <surname>Fenton</surname>
          </string-name>
          ,
          <article-title>A comprehensive scoping review of bayesian networks in healthcare: Past, present and future</article-title>
          ,
          <source>Artificial Intelligence in Medicine</source>
          (
          <year>2021</year>
          )
          <fpage>102108</fpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref6">
        <mixed-citation>
          [6]
          <string-name>
            <given-names>K. P.</given-names>
            <surname>Murphy</surname>
          </string-name>
          , et al.,
          <article-title>Dynamic bayesian networks</article-title>
          ,
          <source>Probabilistic Graphical Models, M. Jordan</source>
          <volume>7</volume>
          (
          <year>2002</year>
          )
          <fpage>431</fpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref7">
        <mixed-citation>
          [7]
          <string-name>
            <given-names>R.</given-names>
            <surname>Peralta</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M.</given-names>
            <surname>Garbelli</surname>
          </string-name>
          ,
          <string-name>
            <given-names>F.</given-names>
            <surname>Bellocchio</surname>
          </string-name>
          ,
          <string-name>
            <given-names>P.</given-names>
            <surname>Ponce</surname>
          </string-name>
          ,
          <string-name>
            <given-names>S.</given-names>
            <surname>Stuard</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M.</given-names>
            <surname>Lodigiani</surname>
          </string-name>
          ,
          <string-name>
            <given-names>J. Fazendeiro</given-names>
            <surname>Matos</surname>
          </string-name>
          ,
          <string-name>
            <given-names>R.</given-names>
            <surname>Ribeiro</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M.</given-names>
            <surname>Nikam</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M.</given-names>
            <surname>Botler</surname>
          </string-name>
          , et al.,
          <article-title>Development and validation of a machine learning model predicting arteriovenous fistula failure in a large network of dialysis clinics</article-title>
          ,
          <source>International Journal of Environmental Research and Public Health</source>
          <volume>18</volume>
          (
          <year>2021</year>
          )
          <fpage>12355</fpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref8">
        <mixed-citation>
          [8]
          <string-name>
            <given-names>G.</given-names>
            <surname>Ducamp</surname>
          </string-name>
          ,
          <string-name>
            <given-names>C.</given-names>
            <surname>Gonzales</surname>
          </string-name>
          ,
          <string-name>
            <given-names>P.-H.</given-names>
            <surname>Wuillemin</surname>
          </string-name>
          , aGrUM/pyAgrum : a
          <article-title>Toolbox to Build Models and Algorithms for Probabilistic Graphical Models in Python</article-title>
          ,
          <source>in: 10th International Conference on Probabilistic Graphical Models</source>
          , volume
          <volume>138</volume>
          <source>of Proceedings of Machine Learning Research</source>
          , Skørping, Denmark,
          <year>2020</year>
          , pp.
          <fpage>609</fpage>
          -
          <lpage>612</lpage>
          . URL: https://hal.archives-ouvertes.fr/hal-03135721.
        </mixed-citation>
      </ref>
      <ref id="ref9">
        <mixed-citation>
          [9]
          <string-name>
            <given-names>D.</given-names>
            <surname>Atienza</surname>
          </string-name>
          ,
          <string-name>
            <given-names>C.</given-names>
            <surname>Bielza</surname>
          </string-name>
          ,
          <string-name>
            <given-names>P.</given-names>
            <surname>Larrañaga</surname>
          </string-name>
          ,
          <article-title>Semiparametric bayesian networks</article-title>
          ,
          <source>Information Sciences 584</source>
          (
          <year>2022</year>
          )
          <fpage>564</fpage>
          -
          <lpage>582</lpage>
          .
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>